Accueil alexia

Biostatistics: Alexia Iasonos Memorial Sloan Kettering Cancer Center

Par un écrivain mystérieux
Last updated 10 juillet 2024
Biostatistics: Alexia Iasonos Memorial Sloan Kettering Cancer Center
Biostatistics: Alexia Iasonos Memorial Sloan Kettering Cancer Center
Time to publication of oncology trials and why some trials are
Biostatistics: Alexia Iasonos Memorial Sloan Kettering Cancer Center
Efficacy of MEK inhibition in patients with histiocytic neoplasms
Biostatistics: Alexia Iasonos Memorial Sloan Kettering Cancer Center
Scientific Review of Phase I Protocols With Novel Dose-Escalation
Biostatistics: Alexia Iasonos Memorial Sloan Kettering Cancer Center
Incorporating lower grade toxicity information into dose finding
Biostatistics: Alexia Iasonos Memorial Sloan Kettering Cancer Center
Handbook of Methods for Designing, Monitoring, and Analyzing Dose-Find
Biostatistics: Alexia Iasonos Memorial Sloan Kettering Cancer Center
Alexia Iasonos and John O'Quigley - ppt download
Biostatistics: Alexia Iasonos Memorial Sloan Kettering Cancer Center
Alexia Iasonos (@AlexiaIasonos) / X
Biostatistics: Alexia Iasonos Memorial Sloan Kettering Cancer Center
Alexia Iasonos (@AlexiaIasonos) / X
Biostatistics: Alexia Iasonos Memorial Sloan Kettering Cancer Center
JCO Special Series Journal of Clinical Oncology
Recommandé pour vous
Tu pourrais aussi aimer

© 2014-2024 jeevanutthan.in. Inc. ou ses affiliés.